RetinaCME
LECTURECME

Thinking Outside the Box When Treating Noninfectious Uveitis

Author(s)/Faculty: Lisa J. Faia, MD; Sumit Sharma, MD
Release Date: 4/12/2019Expiration Date: 4/11/2020
Credit Type: CMENumber of Credits: 0.5
Content Type: LectureProvider:
Noninfectious uveitis is a leading cause of preventable blindness worldwide. To avert potential severe vision loss, timely diagnosis and the initiation of an effective management protocol is imperative. Systemic corticosteroids have been the gold standard and an effective front-line therapy for noninfectious uveitis, but the side effects associated with their long-term administration warrant the utilization of other therapy options. New nonsteroidal therapies have recently been approved, and other agents are currently under investigation for the treatment of noninfectious uveitis. For effective incorporation of these agents in management protocols, it is essential that their optimal use and safety profiles are understood and considered. In this educational activity, experts in the field provide discussion on the need for nonsteroidal options for the long-term management of noninfectious uveitis and evaluate the latest clinical evidence regarding new and emerging nonsteroidal options for long-term treatment of the disease.